TAC1 and burning mouth syndrome: Gabapentin mediates pain attenuation by binding to the α2δ-1 subunit of the voltage calcium channels and inhibits the release of neurotransmitters such as glutamate, CGRP and substance P; the development of chronic pain (49,50) correlates BMS as a neuropathic pain that may involve both central and peripheral mechanisms.